← Analysis page  ·  Pieter Slegers hub  ·  Research hub

Actionable insights — Is L'Oréal an interesting stock?

How to decline a business you rate 7.8/10 for a reason other than price: separate the quality verdict from the growth forecast, let the three valuation methods disagree in public, and convert the "no" into a multiple.
2026-APR-09 · Compounding Quality (Substack) · Pieter Slegers · read ↗ · full analysis · transcript
How to read this page: this is the 15-step worksheet run end to end on a free, public post, so the whole method is visible — thresholds, failures and all. What is worth taking is not the L'Oréal verdict but the machinery: which checks are allowed to fail without killing an idea, which single failure does kill it, and how a pass is turned into a price. Written post, so no timestamps.

1. Separate the two ways a wonderful business can be uninvestable: price and growth

The repeatable method
  1. Finish the quality assessment and score it before opening any valuation work, so the two verdicts cannot contaminate each other.
  2. Then ask two distinct questions. Is the business priced above what it is worth? And separately: is the business still capable of growing fast enough to earn a return at any sensible price?
  3. A price problem is temporary and gives you a watchlist entry. A growth problem is structural and may never resolve — a business at the law-of-large-numbers ceiling does not grow out of it.
  4. Say which of the two is binding, in the verdict itself, so the follow-up action is obvious.
Here: "L'Oréal is a wonderful business but the future growth prospects are too low." The multiple is not the objection — 27.0x forward against a 31.5x ten-year average actually passes the first valuation test. The binding constraint is named in the risk section: "with around $51.7 billion in annual sales, L'Oréal's size makes rapid growth more challenging… the larger a business, the harder it becomes to grow." Contrast the FICO and CTAS passes, both of which turn purely on a multiple.
Watch for

2. Test whether a consumer moat is owned or rented, using the advertising line

The repeatable method
  1. Take advertising and promotion spend as a percentage of revenue and read it as the annual maintenance cost of the brand.
  2. Ask what happens to volumes if that spend is halved for two years. A genuinely owned brand survives it; a rented one does not.
  3. Cross-check against gross margin trend: if margin holds while ad spend as a share of revenue rises, the brand is getting more expensive to defend.
  4. Compare the number to peers in the same category, since the absolute level means little on its own.
Here: "Year after year, L'Oréal spends roughly 32% of its revenue on advertising and promotion expenses. It makes you wonder what is doing the heavy lifting: the brand or the advertising?" The question is raised, left unanswered, and the moat still scored 8.5/10 — the moat is then defended on scale (barriers to reaching relevant size, unit-cost advantage) rather than on brand.
Watch for

3. Run three valuations and let them disagree — the split tells you which risk you are taking

The repeatable method
  1. Method one: forward PE against the company's own ten-year average. This tests sentiment only.
  2. Method two: an earnings-growth model — expected EPS growth + dividend yield ± the annualised effect of the multiple reverting to a stated target. This gives an expected annual return you can compare with a hurdle.
  3. Method three: a reverse DCF — solve for the FCF growth the current price implies, then compare it against the growth actually delivered over the last decade.
  4. Record the verdict of each separately. Agreement is a signal; disagreement tells you exactly which assumption is doing the work.
Here: forward PE 27.0x vs 31.5x ✅; earnings-growth model 7.0% + 1.7% + multiple drift = 8.0% ❌ ("good, but we target a higher expected return"); reverse DCF 13.0% required against 8.7% delivered ❌. The historic-multiple test passes and both forward-looking tests fail — which is the signature of a de-rating that is justified rather than an opportunity.
Watch for

4. Publish the failed thresholds instead of arguing them away

The repeatable method
  1. Fix the thresholds before you look at the company: gross margin >40%, ROIC >15%, ROE >20%, interest coverage >15x, goodwill/assets <20%, CAPEX/sales <5%, net margin >10%, FCF/net income >80%, SBC <10% of net income.
  2. Mark each pass or fail mechanically, and write the fails down next to the passes.
  3. Score each of the 15 sections out of 10 and add them into one Total Quality Score, so a strong section cannot silently rescue a weak one.
  4. Then decide — with the failures visible, not summarised away.
Here: three hard fails are printed: ROIC 13.9% (<15% ❌), ROE 18.0% (<20% ❌) and goodwill/assets 23.4% (>20% ❌) — on a company most investors would describe as a high-return brand machine. The commentary is deliberately flat: "in an ideal world, we would prefer these numbers to be a little bit higher." Total Quality Score 7.8/10 — identical to the score FICO receives six weeks later on a very different business.
Watch for

5. Convert every "no" into a multiple, then into a share price

The repeatable method
  1. State the multiple at which the business would clear your return hurdle, given your growth estimate rather than the market's.
  2. Convert it into a share price and publish both numbers side by side with the current one.
  3. Set the alert at that price; do not revisit the name on a calendar.
  4. Keep the quality work — it does not need redoing when only the price changes.
Here: "I would love to own L'Oréal at 20x earnings. This means I would love to buy L'Oréal at a price of €271 (current stock price: €367.4)" — a required fall of about 26%. Note the level: 20x is materially stricter than the 25x used for CTAS and for FICO, which is the growth objection expressed as a number.
Watch for

6. Read management tenure and family ownership as evidence, not as colour

The repeatable method
  1. Count the number of chief executives across the company's whole life and divide — then compare against the market norm.
  2. Check whether the current CEO is an insider promotion with a long internal history, and how much stock they personally own.
  3. Identify the largest shareholder and whether the stake is inherited, concentrated and board-represented — inherited concentrated stakes cannot be sold quickly, which is what makes them align with the long term.
  4. Only then classify the company: an Owner-Operator label should follow from the ownership facts, not from the narrative.
Here: "the average tenure of a CEO… is 8.1 years. L'Oréal does it differently. In its long history of 115 (!) years, they only had 6 CEOs" — 19 years each. CEO Nicolas Hieronimus joined in 1987 and holds €87.2m of stock; Françoise Bettencourt holds over 29.5% and sits on the board. Scored 9/10, the card's highest mark, and the basis for the Owner-Operator classification.
Watch for

7. Screen on what will not change, and price the mature end market honestly

The repeatable method
  1. Ask Bezos' question in the form used here: what will not change in ten years? Build the durability case on that, not on the growth story.
  2. Then separate durability from growth explicitly — a low risk of disruption is a reason to hold a business a long time, not a reason to pay a growth multiple for it.
  3. Quantify the market's own growth rate independently of the company's (here 6.7% a year to 2030) and check the company's forecast against it.
  4. Where the two are similar, accept that the investment case must come from price rather than from share gains.
Here: "Even though L'Oréal isn't active in a fast-growing industry, the risk of disruption is pretty low. A great company stays great for a long time." The three named tailwinds — ageing populations, "600 million potential new customer by 2030" from the Asian middle class, and skincare — are real and still leave a 5.0% two-year revenue forecast. Durability scored well (outlook 7/10); the growth is what fails.
Watch for

Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.